Supernus Pharmaceuticals | SUPN - PE Price to Earnings


Supernus Pharmaceuticals reported 110.38 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Abbott 30.71 14.41 Dec/2025
ANI Pharmaceuticals 37.99 60.68 Dec/2025
Aurora Cannabis 23.27 0 Sep/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Corcept Therapeutics 41.9 52.28 Dec/2025
Eisai 26.63 0.46 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Novo Nordisk 12.78 0.01 Dec/2025
Pacira 52.68 23.44 Dec/2025
Perrigo 58.96 24.65 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
United Therapeutics 17.32 1.62 Dec/2025